179 related articles for article (PubMed ID: 29207576)
41. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
42. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.
Ha H; Debnath B; Neamati N
Theranostics; 2017; 7(6):1543-1588. PubMed ID: 28529637
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
44. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
Lopes CC; Toma L; Pinhal MA; Porcionatto MA; Sogayar MC; Dietrich CP; Nader HB
Biochimie; 2006 Oct; 88(10):1493-504. PubMed ID: 16793191
[TBL] [Abstract][Full Text] [Related]
45. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
[TBL] [Abstract][Full Text] [Related]
46. Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance.
Onyeisi JOS; Pernambuco Filho PCA; Mesquita APS; Azevedo LC; Nader HB; Lopes CC
Int J Biochem Cell Biol; 2020 Nov; 128():105848. PubMed ID: 32927086
[TBL] [Abstract][Full Text] [Related]
47. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2.
Lippert U; Zachmann K; Henz BM; Neumann C
Exp Dermatol; 2004 Aug; 13(8):520-5. PubMed ID: 15265017
[TBL] [Abstract][Full Text] [Related]
48. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
49. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
Hallak LK; Collins PL; Knudson W; Peeples ME
Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
[TBL] [Abstract][Full Text] [Related]
50. Expression of zebrafish cxcl8 (interleukin-8) and its receptors during development and in response to immune stimulation.
Oehlers SH; Flores MV; Hall CJ; O'Toole R; Swift S; Crosier KE; Crosier PS
Dev Comp Immunol; 2010 Mar; 34(3):352-9. PubMed ID: 19941893
[TBL] [Abstract][Full Text] [Related]
51. CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway.
Sturm A; Baumgart DC; d'Heureuse JH; Hotz A; Wiedenmann B; Dignass AU
Cytokine; 2005 Jan; 29(1):42-8. PubMed ID: 15579377
[TBL] [Abstract][Full Text] [Related]
52. PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo.
Gerlza T; Trojacher C; Jeremic D; Krieger E; Adage T; Kungl A
Cytokine; 2020 Mar; 127():154942. PubMed ID: 31794956
[TBL] [Abstract][Full Text] [Related]
53. Molecular aspects, genomic arrangement and immune responsive mRNA expression profiles of two CXC chemokine receptor homologs (CXCR1 and CXCR2) from rock bream, Oplegnathus fasciatus.
Umasuthan N; Wan Q; Revathy KS; Whang I; Noh JK; Kim S; Park MA; Lee J
Fish Shellfish Immunol; 2014 Sep; 40(1):304-18. PubMed ID: 24945570
[TBL] [Abstract][Full Text] [Related]
54. Studies with neutralizing antibodies suggest CXCL8-mediated neutrophil activation is independent of C-C motif chemokine receptor-like 2 (CCRL2) ligand binding function.
Su Z; Brooks J; Pelker J; Andreyeva T; Sobon H; Gifford R; Powers M; Wang J; Dower C; Hegen M; Messing D; Sheehan AD; Brennan JJ
PLoS One; 2023; 18(1):e0280590. PubMed ID: 36662882
[TBL] [Abstract][Full Text] [Related]
55. Differential Regulation of CXCL8 Production by Different G Protein Subunits with Synergistic Stimulation by Gi- and Gq-Regulated Pathways.
Chan AS; Lau WW; Szeto AC; Wang J; Wong YH
J Mol Biol; 2016 Sep; 428(19):3869-84. PubMed ID: 27040396
[TBL] [Abstract][Full Text] [Related]
56. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model.
Gabellini C; Gómez-Abenza E; Ibáñez-Molero S; Tupone MG; Pérez-Oliva AB; de Oliveira S; Del Bufalo D; Mulero V
Int J Cancer; 2018 Feb; 142(3):584-596. PubMed ID: 28949016
[TBL] [Abstract][Full Text] [Related]
57. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
[TBL] [Abstract][Full Text] [Related]
58. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
59. Leukocyte responses to immobilized patterns of CXCL8.
Girrbach M; Rink I; Ladnorg T; Azucena C; Heißler S; Haraszti T; Schepers U; Schmitz K
Colloids Surf B Biointerfaces; 2016 Jun; 142():385-391. PubMed ID: 26970827
[TBL] [Abstract][Full Text] [Related]
60. Nitration of chemokine CXCL8 acts as a natural mechanism to limit acute inflammation.
Thompson S; Pang CY; Sepuru KM; Cambier S; Hellyer TP; Scott J; Simpson AJ; Proost P; Kirby JA; Rajarathnam K; Sheerin NS; Ali S
Cell Mol Life Sci; 2023 Jan; 80(1):35. PubMed ID: 36622452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
